Description and Early Results of the Kaiser Permanente Southern California COVID-19 Home Monitoring ProgramObservational Study Published on 2021-07-282022-10-05 Journal: The Permanente journal [Category] 임상, [키워드] adverse effect ambulatory patient Analysis appear Care conducted COVID-19 decrease demographics description Dexamethasone died effective enrolled Enrollment home hospital Hospital admission Hospitalization include mitigate monitoring Mortality mortality rate oxygen Patient Program Prospective Study receive receiving receiving oxygen only Remdesivir Result Retrospective study Safe Satisfaction therapy Treatment triggers [DOI] 10.7812/TPP/20.281 PMC 바로가기 [Article Type] Observational Study
Influence of angiotensin converting enzyme inhibitors/angiotensin receptor blockers on the risk of all‐cause mortality and other clinical outcomes in patients with confirmed COVID‐19: A systemic review and meta‐analysisOriginal Article Published on 2021-07-282022-10-29 Journal: Journal of clinical hypertension (Greenwich, Conn. [Category] COVID-19, SARS, [키워드] 95% CI adjusted adverse effect Angiotensin converting enzyme inhibitor angiotensin receptor blocker ARBs association available data benefit Bia blocker cardiac adverse events CBM Clinical outcome CNKI Cochrane Library conducted COVID‐19 COVID‐19 patients COVID‐19 database enzyme hazard ratio Hospital stay hypertension incidence influence inhibitor lower risk mechanical ventilation Mortality Odds ratio outcome pandemic Patient physician Primary outcome readmission receptor reported Result risk secondary Secondary outcomes Systemic review was performed while [DOI] 10.1111/jch.14329 PMC 바로가기 [Article Type] Original Article
CAR-NK Cells Effectively Target SARS-CoV-2-Spike-Expressing Cell Lines In VitroCAR-NK 세포, 시험관 내에서 SARS-CoV-2-스파이크 발현 세포주를 효과적으로 표적화Immunology Published on 2021-07-232022-09-11 Journal: Frontiers in Immunology [Category] MERS, SARS, 변종, 진단, [키워드] acute respiratory syndrome coronavirus addition adverse effect Anticoagulants antigen receptor antivirals approach Cancer CAR CAR (chimeric antigen receptor) Cell cells chimeric antigen receptor conserved conserved region contagious convalescent plasma coronavirus coronavirus 2 coronavirus disease Coronavirus disease 2019 COVID-19 CR3022 current cytokine cytokine production D614G domain E484K E484K variant effective Emergency use escape mutant escape mutants Evidence expressing glycoprotein hematologic immune pressure immune response Immunity immunocompromised condition immunodeficient patients immunomodulators Immunotherapy IMPROVE in vitro include individual isolates kill killing LINE Moderna monoclonal antibody monoclonal antibody therapies mutants N501Y N501Y variant NAbs natural killer neutralizing antibody NK cells off-the-shelf Patient Pfizer Population pseudotyped SARS-CoV-2 virus public health recognize reported respiratory S protein S309 SARS-CoV SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 isolates SARS-CoV-2 neutralizing antibody SARS-CoV-2 S protein SARS-CoV-2 spike SARS-CoV-2 virus scFv Severe acute respiratory syndrome severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 shown Side effect target target cell target cells the vaccines Therapies therapy treat treating COVID-19 Treatment Vaccine Vaccines variants of SARS-CoV-2 [DOI] 10.3389/fimmu.2021.652223 PMC 바로가기 [Article Type] Immunology
The confused puzzles in antineutrophil cytoplasmic antibody‐associated vasculitis activity evaluation: A case reportCase Report Published on 2021-07-232024-09-04 Journal: Clinical Case Reports [Category] 대상포진, [키워드] adverse effect ANCA‐associated vasculitis Disease activity immunosuppressive therapy Infection Mucormycosis [DOI] 10.1002/ccr3.4497 PMC 바로가기 [Article Type] Case Report
Insulin Treatment May Increase Adverse Outcomes in Patients With COVID-19 and Diabetes: A Systematic Review and Meta-AnalysisEndocrinology Published on 2021-07-222022-10-31 Journal: Frontiers in Endocrinology [Category] COVID-19, [키워드] 95% CI 95% CIs 95% confidence interval Admission Adverse adverse effect adverse outcome adverse outcomes articles association calculated CIs Cochrane Library Complication complications concerning conducted coronavirus disease COVID-19 COVID-19 complication diabete diabetes Egger’s test funnel plots Hospitalization identify In-hospital incidence increase increased mortality increased risk insulin Insulin therapy insulin treatment mechanism Meta-analysis Mortality no significant difference objective Odds ratio Patient patients with COVID-19 Result review significantly SMD standardized mean difference Treatment Web of Science were used [DOI] 10.3389/fendo.2021.696087 PMC 바로가기 [Article Type] Endocrinology
Smart City and Crisis Management: Lessons for the COVID-19 PandemicReview Published on 2021-07-212022-10-29 Journal: International Journal of Environmental Research an [Category] COVID-19, SARS, [키워드] adverse effect Analysis catastrophic city Community community well-being COVID-19 COVID-19 pandemic crisis crisis management Critical Digital literacy dissemination Effect ENhance exclusion functional functions inefficient lesson literature review maintain management media mental health mitigate monitoring systems MOST physical Planning recommendation Research Resilience Side effects SmaRT smart city suggested technology urban resilience [DOI] 10.3390/ijerph18157736 PMC 바로가기 [Article Type] Review
Teacher Teleworking during the COVID-19 Pandemic: Association between Work Hours, Work–Family Balance and Quality of LifeArticle Published on 2021-07-162022-10-29 Journal: International Journal of Environmental Research an [Category] Coronavirus, SARS, [키워드] adverse effect age association balance Chilean component COVID-19 COVID-19 pandemic Deterioration distribution Effect evaluate evaluated greater health emergency Impact indicated life media median mental health pandemic participated physical promote Quality Quality of life questionnaire reducing reported risk schoolteachers teacher teleworking work [DOI] 10.3390/ijerph18147566 PMC 바로가기 [Article Type] Article
Can pharmaceutical drugs used to treat Covid-19 infection leads to human health risk? A hypothetical study to identify potential riskCovid-19 감염을 치료하는 데 사용되는 제약 약물이 인간 건강 위험으로 이어질 수 있습니까?잠재적 위험을 식별하기위한 가상의 연구Article Published on 2021-07-152022-08-31 Journal: The Science of the total environment [Category] SARS, 신약개발, 치료제, [키워드] acceptable daily intake activity adverse effect adverse effects affected Analysis approach aquatic environment assumption calculate Can carried Chloroquine Concentration Consumption contaminant contaminated surface COVID-19 COVID-19 infection COVID-19 pandemic determine drug drugs Effect estimate estimates evaluated expected Health hypothetical identify indicated Infection ingestion Lopinavir lopinavir + ritonavir maximum minimum mixture NOAEL novel Novel coronavirus pandemic PECs pharmaceutical Pharmaceuticals potential risk predicted Quotient Rapamycin RATs reduce Regular risk Risk estimation Ritonavir Rivers. Surface water Toxicity treat used to calculate water [DOI] 10.1016/j.scitotenv.2021.146303 PMC 바로가기 [Article Type] Article
Clofazimine for Treatment of Cryptosporidiosis in Human Immunodeficiency Virus Infected Adults: An Experimental Medicine, Randomized, Double-blind, Placebo-controlled Phase 2a Trial인간 면역 결핍 바이러스 감염된 성인에서 cryptosporidiosis의 치료를위한 clofazimine : 실험 의학, 무작위, 이중 맹검, 위약 대조 2A 시험Major Articles and Commentaries Published on 2021-07-152022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] abdominal pain according to protocol adverse effect Analysis antiretroviral ARV ARV therapy ATP blueprint CD4 counts CFZ clinical Clofazimine controls cryptosporidiosis cryptosporidium diarrhea diarrheal did not reduce died double-blind drug Efficacy evaluated failure form HIV HIV population Human Human immunodeficiency virus identify Immunocompromised immunodeficiency virus individual Infection limit malaise Medicine outcome over Part participant pathway Patient performed pharmacokinetics phase Placebo placebo group placebo-controlled study Plasma level Plasma levels primary analysis Primary outcomes Randomized randomized, double-blind, placebo-controlled study reduction in Registration Result Screening Stool Support the placebo group therapeutic therapeutic potential therapy treated Treatment Trial trials Viral Viral load with HIV [DOI] 10.1093/cid/ciaa421 PMC 바로가기 [Article Type] Major Articles and Commentaries
COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?Covid-19 백신 및 혈전증-로드 블록 또는 막 다른 거리?Review Published on 2021-07-132022-09-10 Journal: Biomolecules [Category] SARS, 변종, 유전자 메커니즘, [키워드] Ad26 Ad26.COV2.S addition Adenovirus adenovirus-based adverse effect antibodies approved BNT162b2 cause causes CD147 CD46 cellular ChAdOx1 ChAdOx1 nCoV-19 chronic smokers coronavirus coronavirus disease coronavirus disease-2019 COV2.S COVID-19 elicited EMA European Medicines Agency event Frequency Genetic groups heparan sulfate immune immunological mechanism in some incidence individual Interaction low frequency mRNA-based vaccines Platelet platelet factor 4 Proteoglycan recent receptor receptors reducing reported risk SARS-CoV-2 SARS-CoV-2 spike protein Smokers Spike protein splice sulfate the spike protein thrombocytopenia thrombosis thrombotic Thrombotic thrombocytopenia vaccination vaccine administration Vaccines variant Viral viral disease Viral diseases Viral vector viral vectors [DOI] 10.3390/biom11071020 PMC 바로가기 [Article Type] Review